8Tamura S,Nishigaki T,Moriwaki Y,et al.Tumor markers in pleural effeusion diagnosis[J].Cancer,1998,61(2):298-299.
9Muraki M,Tohda Y,Lwanga T,et al.Assessment of serum Cyfra 21-1 in lung cancer[J].Cancer,1996,77:1274-1275.
10Hoefler H,Denk H.Immunohistochemical demonstration of cytokeratins in gastrointestinal carcinoids and their probable precursors cells[J]. Virchows Arch B Cell Pathol,1984,403:235～240.
5Jemal A, Siegel R, Ward E, et al. Cancer statistics 2009[J]. CA Cancer J Clin, 2009,59(4):225-249.
6Shitrit D, Zingerman B, Shitfit AB, et al. Diagnostic vanue of CYFRA21-1,CEA, CAI99,CA153, and CA125 assays in pleural effusions:analysis of 116 cases and review of the literature[J]. Oncologist, 2005,10(7) : 501-507.
7Ruibal A, Nunez MI, Rodriguez J, et al. Cytosolie levels of neuron specific enolase in squamous cell carcinomas of the lung[T]. Int J Biol Markers, 2003,18(3):188-194.
8秦风展 陈振东 樊青霞.肿瘤内科治疗学[M].北京:人民军医出版社,2004.481-482.
9Spira A, Ettinger DS. Muhidisciplinary management of lung cancer [J]. N Engl J Med,2004,350(4) :379-392.
10Kawachi R, Nakazato Y,Takei H, et al. Clinical significance of pre- operative carcinoem bryonic antigen level for clinical stage I non- small cell lung cancer: can preoperative cancinoembryonic antigen level predict pathological stage [ J ]. Interact Cardiovasc Thorac Surg,2009,9 (2) :199-202.
